Advanced International Journal for Research

E-ISSN: 3048-7641   •   Impact Factor: 9.11

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6, Issue 6 (November-December 2025) Submit your research before last 3 days of December to publish your research paper in the issue of November-December.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 6
November-December 2025

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

AI-Driven Strategies to Forecast and Combat Antibiotic Resistance

Author(s) Ms. Vinutha A, Dr. Shivashankar Govindhan, Dr. Mohankumar L, Dr. Abhishek U N, Dr. Prashanth K
Country India
Abstract Antimicrobial resistance (AMR) is a pressing global health emergency fuelled by the overuse and misuse of antibiotics and threatens human and animal health. Conventional diagnostic and therapeutic approaches tend to be slow, resource-consuming, and of limited predictive ability. Artificial intelligence (AI) and machine learning (ML) advancements provide disruptive potential to predict, prevent, and regulate AMR. Artificial intelligence -driven models can handle and analyse complex, advanced clinical, genomic, and epidemiologic information to predict patterns of resistance, guide antibiotic selection, and maximize stewardship programs. Applications range from rapid diagnostic testing, decision support systems, and drug discovery platforms to novel approaches like AI-assisted antimicrobial peptide design and nanoparticle therapeutics. . Promising as these are, there are barriers to their uptake in the form of data quality, model bias, explain ability, infrastructure requirements, and regulatory adoption. This review integrates state-of-the-art, technology innovation, and prospective AI-based AMR management and emphasizes the need for multidisciplinary team effort in facilitating innovation and harvesting AI potential into clinical and public health applications.
Keywords Antibiotics , Resistance, Machine – learning, Therapeutics , Nanoparticles, Public health,Therapeutics
Field Medical / Pharmacy
Published In Volume 6, Issue 5, September-October 2025
Published On 2025-09-27
DOI https://doi.org/10.63363/aijfr.2025.v06i05.1424
Short DOI https://doi.org/g95hw6
View / Download PDF File

Share this



E-ISSN 3048-7641
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

AIJFR DOI prefix is
10.63363/aijfr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About AIJFR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-79-39-59 editor@aijfr.com